Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katsue Suzuki-Inoue

Showing results (1-10 of 104) with videos related to

Pageof 11
Sort By:
Platelets|June 5, 2018
Roles of the CLEC-2-podoplanin interaction in tumor progressionKatsue Suzuki-Inoue
Hematology. American Society of Hematology. Education Program|December 7, 2019
Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplaninKatsue Suzuki-Inoue
Blood|November 29, 2019
Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplaninKatsue Suzuki-Inoue
Journal of Biochemistry|June 23, 2011
Essential in vivo roles of the platelet activation receptor CLEC-2 in tumour metastasis, lymphangiogenesis and thrombus formationKatsue Suzuki-Inoue
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 2, 2009
CLEC-2, the novel platelet activation receptor and its internal ligand, podoplaninKatsue Suzuki-Inoue
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 29, 2014
[Activation and inhibitory mechanisms of blood platelets]Katsue Suzuki-Inoue
Platelets|September 12, 2018
Platelets and cancer: pathology and drug targetsKatsue Suzuki-Inoue
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 10, 2014
[Role of platelets in lymphangiogenesis]Katsue Suzuki-Inoue
Blood|April 8, 2017
CLEC-2/podoplanin and thromboinflammationKatsue Suzuki-Inoue
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 2, 2024
[The novel in vivo platelet activation marker, soluble CLEC-2]Katsue Suzuki-Inoue
Pageof 11

Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Platelets|June 5, 2018
Roles of the CLEC-2-podoplanin interaction in tumor progressionKatsue Suzuki-Inoue
Hematology. American Society of Hematology. Education Program|December 7, 2019
Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplaninKatsue Suzuki-Inoue
Blood|November 29, 2019
Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplaninKatsue Suzuki-Inoue
Journal of Biochemistry|June 23, 2011
Essential in vivo roles of the platelet activation receptor CLEC-2 in tumour metastasis, lymphangiogenesis and thrombus formationKatsue Suzuki-Inoue
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 2, 2009
CLEC-2, the novel platelet activation receptor and its internal ligand, podoplaninKatsue Suzuki-Inoue
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 29, 2014
[Activation and inhibitory mechanisms of blood platelets]Katsue Suzuki-Inoue
Platelets|September 12, 2018
Platelets and cancer: pathology and drug targetsKatsue Suzuki-Inoue
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 10, 2014
[Role of platelets in lymphangiogenesis]Katsue Suzuki-Inoue
Blood|April 8, 2017
CLEC-2/podoplanin and thromboinflammationKatsue Suzuki-Inoue
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 2, 2024
[The novel in vivo platelet activation marker, soluble CLEC-2]Katsue Suzuki-Inoue
Pageof 11